AI 기반 임상시험 사이트 적합성 평가 시장 보고서(2025년)

Artificial intelligence (AI)-powered clinical trial site feasibility refers to platforms and services that use advanced algorithms to assess and identify the most suitable clinical trial sites. These solutions process large datasets to forecast site performance and patient recruitment potential. They improve the speed and accuracy of decision-making, reduce the likelihood of trial delays, and streamline feasibility assessments while enhancing overall operational efficiency.

The primary component types of AI-powered clinical trial site feasibility are software and services. Software consists of AI-driven platforms and tools that evaluate trial data, site performance, and patient demographics to optimize site selection and feasibility. Deployment options include cloud-based and on-premises models, supporting applications such as site selection, patient recruitment, protocol design, performance analytics, and more. Key end-users include pharmaceutical companies, contract research organizations, academic research institutes, hospitals, and other healthcare entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence (AI)-powered clinical trial site feasibility market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-powered clinical trial site feasibility market statistics, including artificial intelligence (AI)-powered clinical trial site feasibility industry global market size, regional shares, competitors with a artificial intelligence (AI)-powered clinical trial site feasibility market share, detailed artificial intelligence (AI)-powered clinical trial site feasibility market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered clinical trial site feasibility industry. The artificial intelligence (AI)-powered clinical trial site feasibility market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI)-powered clinical trial site feasibility market size has grown exponentially in recent years. It will grow from $1.24 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 23.8%. Growth during the historic period was driven by the rising adoption of AI in clinical research, increasing demand for faster patient recruitment, expansion of decentralized clinical trials, advancements in electronic data capture systems, and regulatory support for innovative trial designs.

The artificial intelligence (AI)-powered clinical trial site feasibility market size is expected to see exponential growth in the next few years. It will grow to $3.55 billion in 2029 at a compound annual growth rate (CAGR) of 23.4%. Growth in the forecast period is expected to be fueled by the integration of real-world data with AI analytics, expansion of virtual clinical trial platforms, rising investment in precision medicine, adoption of predictive modeling for site selection, and development of adaptive trial designs powered by AI. Key trends anticipated for the forecast period include the use of predictive analytics to optimize site selection, integration of real-world data to strengthen feasibility assessments, deployment of machine learning algorithms to forecast patient recruitment, adoption of cloud-based AI platforms for collaborative trial planning, and application of natural language processing to evaluate site performance data.

The increase in clinical trials is contributing to the expansion of the market due to rising demand for improved trial site selection and participant enrollment. The anticipated growth in clinical trials is expected to drive the artificial intelligence powered clinical trial site feasibility market in the future. Clinical trials are research studies conducted worldwide to evaluate the safety and effectiveness of new medical treatments, drugs, and devices. This rise in clinical trials is largely the result of increased funding in biomedical research and development, as both public and private sectors acknowledge the urgent need for innovative healthcare solutions. The expansion of clinical trials fuels the need for artificial intelligence powered feasibility tools, as research organizations require advanced systems to identify the most suitable locations, evaluate site performance, and estimate enrollment success. For example, in November 2023, the Association of the British Pharmaceutical Industry reported that the number of industry-sponsored clinical trials initiated in the United Kingdom grew by 4.3 percent, increasing from 394 trials in 2021 to 411 in 2022. As a result, the growing number of clinical trials is driving the demand for artificial intelligence powered clinical trial site feasibility solutions.

Key companies operating in the artificial intelligence powered clinical trial site feasibility market are concentrating on the development of advanced tools such as artificial intelligence based feasibility and recruitment platforms to enhance site selection and streamline operations within clinical trials. These platforms use artificial intelligence and machine learning technologies to evaluate trial protocols and site data, allowing for better identification of clinical sites and more effective patient recruitment through accurate participant matching. This accelerates trial timelines and increases the chances of success. For example, in June 2023, ObjectiveHealth, a company based in the United States that offers integrated research and technology services, introduced ObjectiveScreen, a platform powered by artificial intelligence that improves clinical trial outcomes by enhancing patient identification, prequalification, and retention. It connects directly with electronic health records and applies machine learning algorithms to identify high-risk individuals and match them with appropriate trials, thereby speeding up recruitment and improving overall trial performance.

In February 2023, ZS Associates, a United States based technology and consulting firm, acquired Trials.ai for an undisclosed amount. This acquisition aims to strengthen ZS Associates' role in the healthcare industry by enhancing the efficiency of clinical trials, shortening the time required to bring therapies to market, and improving the experience of trial participants. Trials.ai is a United States based company focused on healthcare that provides artificial intelligence and analytics solutions to support and improve clinical trial site feasibility.

Major players in the artificial intelligence (AI)-powered clinical trial site feasibility market are Oracle Corporation, Thermo Fisher Scientific Inc., NVIDIA Corporation, IQVIA Holdings Inc., Labcorp Holdings Inc., Dassault Systemes SE, Parexel International Corporation, ZS Associates Inc., Veeva Systems Inc., Verily Life Sciences LLC, Signant Health Holding Corp., Saama Technologies LLC, Elligo Health Research Inc., ConcertAI Inc., Medable Inc., Science 37 Inc., Castor EDC Inc., Unlearn.AI Inc., Antidote Technologies Inc., Deep 6 AI.

North America was the largest region in the artificial intelligence (AI)-powered clinical trial site feasibility market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-powered clinical trial site feasibility report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-powered clinical trial site feasibility market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-powered clinical trial site feasibility market includes revenues earned by providing services such as site identification and selection, predictive enrollment modeling, investigator performance analysis, risk assessment and mitigation, and patient population analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai)-powered clinical trial site feasibility market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-powered clinical trial site feasibility ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-powered clinical trial site feasibility market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Services
• 2) By Deployment Mode: Cloud-Based; On-Premises
• 3) By Application: Site Selection; Patient Recruitment; Protocol Design; Performance Analytics; Other Applications
• 4) By End-User: Pharmaceutical Companies; Contract Research Organizations; Academic Research Institutes; Hospitals; Other End-Users
• Subsegments:
• 1) By Software: Predictive Analytics Software; Machine Learning (ML) Platforms; Natural Language Processing (NLP) Tools; Data Visualization Software; Clinical Trial Management System (CTMS) Integration Software; Real-World Data (RWD) Analytics Software; Risk-Based Monitoring (RBM) Software
• 2) By Services: Feasibility Assessment Services; Site Selection Services; Patient Recruitment Support Services; Data Management And Analytics Services; Protocol Optimization Services; Regulatory Compliance Support Services; Consulting And Advisory Services
• Companies Mentioned: Oracle Corporation; Thermo Fisher Scientific Inc.; NVIDIA Corporation; IQVIA Holdings Inc.; Labcorp Holdings Inc.; Dassault Systemes SE; Parexel International Corporation; ZS Associates Inc.; Veeva Systems Inc.; Verily Life Sciences LLC; Signant Health Holding Corp.; Saama Technologies LLC; Elligo Health Research Inc.; ConcertAI Inc.; Medable Inc.; Science 37 Inc.; Castor EDC Inc.; Unlearn.AI Inc.; Antidote Technologies Inc.; Deep 6 AI
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Characteristics

3. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Trends And Strategies

4. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Total Addressable Market (TAM)

6. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Segmentation

• 6.1. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Services
• 6.2. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cloud-Based
• On-Premises
• 6.3. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Site Selection
• Patient Recruitment
• Protocol Design
• Performance Analytics
• Other Applications
• 6.4. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Contract Research Organizations
• Academic Research Institutes
• Hospitals
• Other End-Users
• 6.5. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predictive Analytics Software
• Machine Learning (ML) Platforms
• Natural Language Processing (NLP) Tools
• Data Visualization Software
• Clinical Trial Management System (CTMS) Integration Software
• Real-World Data (RWD) Analytics Software
• Risk-Based Monitoring (RBM) Software
• 6.6. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Feasibility Assessment Services
• Site Selection Services
• Patient Recruitment Support Services
• Data Management And Analytics Services
• Protocol Optimization Services
• Regulatory Compliance Support Services
• Consulting And Advisory Services

7. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 8.1. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 9.1. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 9.2. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 10.1. India Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 11.1. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 11.2. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 12.1. Australia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 13.1. Indonesia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 14.1. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 14.2. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 15.1. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 15.2. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 16.1. UK Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 17.1. Germany Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 18.1. France Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 19.1. Italy Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 20.1. Spain Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 21.1. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 21.2. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 22.1. Russia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 23.1. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 23.2. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 24.1. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 24.2. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 25.1. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 25.2. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 26.1. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 26.2. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 27.1. Brazil Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 28.1. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 28.2. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

• 29.1. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Overview
• 29.2. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Competitive Landscape
• 30.2. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Company Profiles
  • 30.2.1. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Other Major And Innovative Companies

• 31.1. Dassault Systemes SE
• 31.2. Parexel International Corporation
• 31.3. ZS Associates Inc.
• 31.4. Veeva Systems Inc.
• 31.5. Verily Life Sciences LLC
• 31.6. Signant Health Holding Corp.
• 31.7. Saama Technologies LLC
• 31.8. Elligo Health Research Inc.
• 31.9. ConcertAI Inc.
• 31.10. Medable Inc.
• 31.11. Science 37 Inc.
• 31.12. Castor EDC Inc.
• 31.13. Unlearn.AI Inc.
• 31.14. Antidote Technologies Inc.
• 31.15. Deep 6 AI

32. Global Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

34. Recent Developments In The Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market

35. Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence (AI)-Powered Clinical Trial Site Feasibility Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer